Delivery Order SPE2DB24D1006-SPE2DB25FCFDT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,080.32. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10.75K with a completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio. The place of performance is located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $5,174.25. This is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is not subject to any set-aside designation and is scheduled for completion by September 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- On July 23, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,035.56 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $8,140.82 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, classified as a Firm Fixed Price contract, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a routine pharmaceutical supply transaction executed through AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $14,901.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract is not designated as a set-aside and represents a child order issued under a larger contract vehicle....
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCFDTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes with a ceiling value of $1,034.85. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal procurement requirements across its pharmaceutical and medical supply portfolio. This delivery order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medical products to support military and federal healthcare systems worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company serves critical customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/19/25 |